Hidden cost climate risk leaves on every balance sheet

Hidden Cost: Climate Risk Leaves Its Mark on Every Balance Sheet

Hidden cost climate risk leaves on every - Climate risk has long been sidelined as a secondary concern, often confined to sustainability reports and policy discussions rather than core business strategy. This perception is changing, as the financial implications of climate disruptions become undeniable. For India’s pharmaceutical sector, the stakes are particularly high: the availability of essential medicines is now directly tied to the country’s ability to manage environmental threats.

The Escalating Threats

India is contending with increasingly intricate and severe climate threats, such as floods, heatwaves, and cyclones, which disrupt critical sectors like manufacturing, logistics, and port operations. These events are no longer distant possibilities—they are unfolding realities that challenge operational stability. When supply chains falter, the affordability of medicines declines, disproportionately affecting the most vulnerable populations. Climate-related illnesses further strain healthcare systems already operating near capacity.

"That distinction no longer holds. Climate risk is an economic force—disrupting operations, inflating costs, and reshaping asset values."

Structural Responses and National Commitments

Addressing climate risk requires systemic action, beginning with governance. CFOs and board members must integrate it as a live variable in capital allocation, budgeting, and infrastructure planning—not as an isolated sustainability initiative. India’s national targets, including 500 GW of non-fossil energy capacity by 2030 and net-zero emissions by 2070, provide a clear roadmap for aligning corporate strategies with broader energy transitions. Simultaneously, the government is launching a net-zero portal under the ministry of environment, forest and climate change, promoting voluntary climate action reporting and enhancing accountability.

Companies that align with these signals avoid costly corrections later. Those lagging risk being re-evaluated by markets and regulators, facing higher costs and diminished competitiveness.

Operational Resilience and Strategic Advantage

While governance sets the stage, operational execution determines outcomes. Extreme weather events create unpredictable disruptions, threatening manufacturing continuity and last-mile delivery. For pharmaceutical firms, a broken supply chain isn’t just a financial issue—it’s a gap in patient care. Resilient infrastructure, supplier diversification, and reduced concentration risk are no longer optional; they’re foundational to maintaining uninterrupted operations. Early adopters are seeing measurable benefits, including stable cash flows and quicker recovery times, which translate into a lasting strategic edge.

Scope 3 Emissions and Global Accountability

Scope 3 emissions, stemming from suppliers, packaging, and logistics, represent the largest portion of India’s corporate carbon footprint—often 70–90% in industries like pharma and FMCG. These emissions are now under intense global scrutiny, particularly in export markets such as the EU and US, where regulations like the CBAM framework are reshaping trade dynamics. Failing to manage Scope 3 risks not only jeopardizes export prospects but also increases procurement expenses and weakens climate resilience across the entire value chain.

Technology as the Enabler

Without the right technology, effective climate management remains elusive. Climate-tech is emerging as a critical tool for financial planning, offering predictive analytics to mitigate raw material price swings and enabling low-emission manufacturing to cut operating costs. These investments are not just compliance measures—they’re direct drivers of asset efficiency and long-term market position.

India’s progress is notable: non-fossil energy sources now supply the majority of new electricity generation, with renewable capacity expanding rapidly. Within this context, companies like Lupin are leading the way, with renewables accounting for ~50% of their energy mix in India. The quality of adaptation strategies increasingly defines industry leaders.

Capital markets are factoring climate readiness and ESG performance into valuations and lending decisions, treating them as key risk indicators. As the landscape evolves, businesses that proactively address climate challenges are better positioned to thrive.